| Literature DB >> 25069581 |
Hwa Jun Cha1, Ok-Yeon Kim1, Gang Tai Lee2, Kwang Sik Lee2, Jae Ho Lee3, In-Chul Park4, Su-Jae Lee5, Yu Ri Kim6, Kyu Joong Ahn6, In-Sook An1, Sungkwan An1, Seunghee Bae7.
Abstract
Ultraviolet (UV) radiation impairs intracellular functions by directly damaging DNA and by indirectly generating reactive oxygen species (ROS), which induce cell cycle arrest and apoptosis. UV radiation can also alter gene expression profiles, including those of mRNA and microRNA (miRNA). The effects of UV radiation on cellular functions and gene expression have been widely documented in human skin cells such as keratinocytes, melanocytes and dermal fibroblasts, but the effect it has on other types of skin cell such as dermal papilla cells, which are crucial in the induction of hair follicle growth, remains unknown. In the current study, the effect of UV radiation on physiological changes and miRNA-based expression profiles in normal human dermal papilla cells (nHDPs) was investigated. UVB radiation of ≥50 mJ/cm2 displayed high cytotoxicity and apoptosis in a dose-dependent manner. In addition, ROS generation was exhibited in UVB-irradiated nHDPs. Furthermore, using miRNA microarray analysis, it was demonstrated that the expression profiles of 42 miRNAs in UVB-irradiated nHDPs were significantly altered compared with those in the controls (35 upregulated and 7 downregulated). The biological functions of the differentially expressed miRNAs were studied with gene ontology analysis to identify their putative target mRNAs, and were demonstrated to be involved in cell survival- and death-related functions. Overall, the results of the present study provide evidence that miRNA‑based cellular mechanisms may be involved in the UVB-induced cellular response in nHDPs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25069581 PMCID: PMC4148374 DOI: 10.3892/mmr.2014.2418
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952
Figure 1Effect of UVB irradiation on cell viability, ROS production and the cell cycle in nHDPs. (A) Effect of UVB radiation on nHDP viability. Cell viability was measured by MTT assay. Results are presented as the mean ± standard error of the percentage of control OD of triplicate samples. *P<0.05 vs. 0 mJ/cm2 UVB irradiation. (B) Effect of UVB on the levels of ROS in nHDPs. Different cell populations are represented by different colors (black, 0 mJ/cm2 UVB; white, 50 mJ/cm2 UVB). (C) Effect of UVB on the cell cycle in nHDPs. The distributions of cells of different populations in the different stages of the cell cycle were analyzed by flow cytometry using PI-stained nHDPs. The frequency of cells in the sub-G1 phase is presented as the mean ± standard error of the percentage of the gated cell population of triplicate samples. UVB, ultraviolet B; DCF-DA, 2′,7′-dichloroflorescein diacetate; PI, propidium iodide; ROS, reactive oxygen species; nHDP, normal human dermal papilla cell; OD, optical density.
Figure 2UVB radiation alters miRNA expression profiles in nHDPs. (A) Heat-map of miRNAs whose expressions levels were up- and downregulated >1.5-fold in 50 mJ/cm2 UVB-irradiated nHDPs vs. non-irradiated nHDPs. The color bar displaying fluorescence intensity corresponds to miRNA expression levels. Highly expressed miRNAs are red, while those present at low levels are blue. (B) Total number of miRNAs up- and downregulated by 50 mJ/cm2 UVB radiation in nHDPs. UVB, ultraviolet B; miRNA, microRNA; nHDP, normal human dermal papilla cell.
miRNAs upregulated at least 1.5-fold in UVB-irradiated nHDPs.
| miRNA | Fold change | Chr |
|---|---|---|
| hsa-miR-1207-5p | 2.00 | chr8 |
| hsa-miR-1225-5p | 1.62 | chr16 |
| hsa-miR-1246 | 1.79 | chr2 |
| hsa-miR-1275 | 1.76 | chr6 |
| hsa-miR-138-5p | 1.80 | chr3 |
| hsa-miR-150-3p | 2.24 | chr19 |
| hsa-miR-181a-5p | 1.56 | chr1 |
| hsa-miR-1915-3p | 2.19 | chr10 |
| hsa-miR-193a-3p | 2.32 | chr17 |
| hsa-miR-1973 | 2.18 | chr4 |
| hsa-miR-222-3p | 2.07 | chrX |
| hsa-miR-26a-5p | 2.08 | chr3 |
| hsa-miR-27a-3p | 1.90 | chr19 |
| hsa-miR-2861 | 2.42 | chr9 |
| hsa-miR-29b-3p | 2.25 | chr1 |
| hsa-miR-30a-5p | 4.03 | chr6 |
| hsa-miR-30d-5p | 2.28 | chr8 |
| hsa-miR-3162-5p | 2.20 | chr11 |
| hsa-miR-3195 | 1.85 | chr20 |
| hsa-miR-337-5p | 1.62 | chr14 |
| hsa-miR-34a-5p | 1.64 | chr1 |
| hsa-miR-34b-5p | 1.76 | chr11 |
| hsa-miR-361-5p | 2.12 | chrX |
| hsa-miR-3651 | 1.55 | chr9 |
| hsa-miR-3663-3p | 2.16 | chr10 |
| hsa-miR-3665 | 2.34 | chr13 |
| hsa-miR-379-5p | 2.09 | chr14 |
| hsa-miR-381-3p | 1.51 | chr14 |
| hsa-miR-423-5p | 1.78 | chr17 |
| hsa-miR-4281 | 2.09 | chr5 |
| hsa-miR-630 | 2.35 | chr15 |
| hsa-miR-638 | 2.55 | chr19 |
| hsa-miR-762 | 1.89 | chr16 |
| hsa-miR-92a-3p | 1.74 | chr13 |
| hsa-miR-99b-5p | 3.28 | chr19 |
miRNA, microRNA; UVB, ultraviolet B; nHDP, normal human dermal papilla cell; Chr, chromosome.
miRNAs downregulated at least 1.5-fold in UVB-irradiated nHDPs.
| miRNA | Fold change | Chr |
|---|---|---|
| hsa-miR-1207-5p | 2.00 | chr8 |
| hsa-miR-1225-5p | 1.62 | chr16 |
| hsa-miR-1246 | 1.79 | chr2 |
| hsa-miR-1275 | 1.76 | chr6 |
| hsa-miR-138-5p | 1.80 | chr3 |
| hsa-miR-150-3p | 2.24 | chr19 |
| hsa-miR-181a-5p | 1.56 | chr1 |
miRNA, microRNA; UVB, ultraviolet B; nHDP, normal human dermal papilla cell; Chr, chromosome.
Figure 3Scheme of bioinformatic analysis performed. miRNAs whose expression profiles were altered by UVB irradiation were selected by comparing the microarray data of non-irradiated and 50 mJ/cm2 UVB-exposed nHDPs. Predicted targets of the UVB-specific miRNAs were determined using TargetScan software. The target genes were then categorized into three groups, namely apoptosis, cell cycle, and cell growth and proliferation by performing GO analysis. UVB, ultraviolet B; miRNA, microRNA; nHDP, normal human dermal papilla cell; GO, gene ontology.
Predicted target genes of the top five most differentially upregulated miRNAs in UVB-irradiated nHDPs.
| Target genes and functions | |||
|---|---|---|---|
|
| |||
| miRNA | Cell cycle | Apoptosis | Cell growth and proliferation |
| hsa-miR-30a-5p | APBB2, RHOB, EPHB2, NF1 NOTCH2, PNN, TSC1, RECK, CUL3, CUL2, BCL10, MTBP, TBRG1, TBRG1 | ACTC1, CASP3, GJA1, HTT, IL1A, IL2RA, IL17A, MAP3K5, MLL, NAIP, PTGER3, ATXN1, TFDP1, TIA1, UNC5C, TNFSF9, TNFRSF10D, BCL10, ATG12, EBAG9, ARHGEF6, ATG5, BCL2L11, EDAR, TRIM35, SIRT1, TCTN3, CECR2, SH3KBP1, DDIT4, C8orf4, AVEN, BIRC6, TRIB3, NLRP3, RFFL, TICAM1, PRUNE2, RNF144B, BCL2L15 | ADRA1D, ADRA2A, ADRB2, IL7, TLX1, BNC1, DDX11, CAMK2D, JAG2, KRAS, LIFR, LYN, MAFG, PDGFRB, PPP2CA, SOX9, VIPR1, CDC7, CUL3, SOCS1, CREG1, NOV, SOCS3, EBAG9, CFDP1, ENOX2, C19orf10, BIRC6, CDCA7 |
| hsa-miR-99b-5p | MCC, RASSF4 | DFFB, NLRP2, RNF144B | BMPR2, IGF1R, STAT5B |
| hsa-miR-638 | CDKN2B, MCC, MPHOSPH1, XAF1 | CLU, ATN1, TNFRSF11B, PAK2, TNFRSF1B, ATG5, CIDEB, SAP30BP, XAF1, UBE2Z, FAM130A1, RHOT2, RFFL | CD47, CDK2, CLU, CTF1, GAP43, IFNG, IL11, LIF, LIFR, PAK2, TRAF5, VEGFA, HOXB13, BRD8 |
| hsa-miR-2861 | - | - | - |
| hsa-miR-630 | RHOB, CDKN2B, CYLD, NOTCH2, RB1CC1, WWOX, ZAK, C11orf82, LIN9 | XIAP, DOCK1, EP300, GJA1, PAX3, TP63, ATG12, SLK, SMNDC1, NCKAP1, CKAP2, CROP, ZAK, DDIT4, AVEN, ZMAT3, TP53INP1, C11orf82 | BMPR2, KLF5, FOXO1, IGF1R, CYR61, IL7, SSR1, TDGF1, TGFBR2, CDC7, SOCS2, RBM9, CCDC88A, ZMAT3 |
miRNA, microRNA; UVB, ultraviolet B; nHDP, normal human dermal papilla cell.
Predicted target genes of the top five most differentially downregulated miRNAs in UVB-irradiated nHDPs.
| Target genes and functions | |||
|---|---|---|---|
|
| |||
| miRNA | Cell cycle | Apoptosis | Cell growth and proliferation |
| hsa-miR-218-5p | TRIM13, CDK6, CDKN1B, KHDRBS1, CETN2, MAPRE2, RCC1, FOXN3, PYHIN1, DCC, E2F2, SENP5, FANCD2, MAPRE3, SEPT2, SASH1, CLASP1, SPECC1L, SH3BP4, EGFL6, PDCD4, HLA, QB1, HPGD, BIRC5, MCC, NEDD9, ZAK, ANLN, PPP1CB, PPP1CC, RIF1, RCBTB1, FANCI, SMPD3, PCNP, CCND1, SIAH2, BRCA1, TACC1, PTP4A1, MAP9, RASSF5, PARD6B, CCNA2, CCND3, LYK5, RASSF2 | - | NAMPT, CDKN1B, NET1, SOCS4, CTGF, FLT1, KIT, KRT6A, LIF, LIFR, MST1R, NEDD9, NODAL, NRAS, PAK2, C20orf20, BIRC6, PURA, APPA2, BNC1, SHC1, SSR1, TRAF5, YEATS4, CUL3, SOCS3, SOCS6, HTRA3, CD47, SOCS5 |
| hsa-miR-450a-5p | RCC1, EGFR, CD2AP, XAF1 | - | - |
| hsa-miR-299-5p | CDKN1A, MAEA, SMC2, CTCF, SPIN1, POLS, CEP110, FOXN3, GADD45A, AHR, SENP5 , FANCD2, SIRT2, SEP2, CCNDBP1, CD2AP, RABGAP1, KIF11, NF1, NPAT, ZAK, MPHOSPH8, PPP1CB, CEP55, MTUS1, RAD21, RAP1A, AVPI1, SIAH1, PTP4A1, CDC7, PPAPDC1B, MCM8, TBRG1, CDC16, CCNG1, CCNG2, CCNH, AURKB, HDAC4 | - | IGFBP3, IL8RB, NOV, SIRPG, SSR1, TDGF1, CDC7, SOCS6, CD86, SOCS5 |
| hsa-miR-374a-5p | CDK6, SPIN1, POLS, ZWINT, ADCYAP1, ESCO2, SLC5A8, GADD45A, AHR, CCRK, CD2AP, NIPBL, EGFL6, APPL1, GAS1, MTBP, LIN9, ANXA1, HELLS, HPGD, FLJ44060, ING1, LOH11CR2A, MCM2, MCM6, MLH1, NBN, ATM, NEDD9, NEK2, NF1, ZAK, ANLN, ERBB2IP, MAPK1, MAPK6, MAPK7, PCNP, PTEN, SPC25, ARHGAP20, CCND1, NCAPG, PAPD5, BMP2, NEK4, TACC1, TFDP1, TP53BP2, SUV39H2, MAP9, CHAF1B, RECK, MCM8, PARD6B, TBRG1, CDC14A, BCL10, STARD13, CCNE2, KNTC1 | - | NAMPT, DNAJA2, UBE2E3, CHAD, CLU, SOCS4, HES1, IGFBP3, IGFBP7, IL7, CXCL10, KRAS, LIFR, MYC, NEDD9, PAK2, CRIM1, PURA, BCL2, PAPPA2, CXCL5, SLAMF1, BTC, TBX3, TSHR, VEGFA, YEATS4, SOCS6, CIAO1, NTN1, CD47, SOCS5 |
| hsa-miR-495-3p | CDKN1A, MAEA, SMC2, CTCF, SPIN1, POLS, CEP110, FOXN3, GADD45A, AHR, SENP5, FANCD2, SIRT2, SEP2, CCNDBP1, CD2AP, RABGAP1, KIF11, NF1, NPAT, ZAK, MPHOSPH8, PPP1CB, CEP55, MTUS1, RAD21, RAP1A, AVPI1, SIAH1, CD2AP, SH3BP4, CADM1, ANAPC13, GAS1, LIN9, UHRF1, HHEX, TMPRSS11A, ING1, JAG2, LIG4, AD2L1, MCC, MCM2, MCM3, MCM7, NBN, EDD9, PNN, ANLN, XRN1, TXNL4B, TIPIN, PPP1CB, RIF1, RCBTB1, PPP6C, CCAR1, SEP11, BIN3, ERBB2IP, KLK10, PCNP, PTCH1, PTEN, SPC25, ARHGAP20, RAD17, RAP1A, CCND1, NCAPG, PAPD5, SIAH1, BMP2, NEK4, TACC1, BUB1, TFDP1, WEE1, EVI5, HMGA2, CDC7, RASSF5, CUL4B, PARD6G, JUB, CDC14A, RUNX3, PCAF, BCL10, UBA3, CCNT2, PKMYT1, CCNE2, ZNF830, CCPG1, WTAP, MDC1, HDAC4, DLGAP5, MTSS1, RB1CC1, CDC2, TLK1, CDC6, DLEC1, CASP8AP2, SEP7 | - | CDKN1B, NET1, TNFSF13B, MORF4L1, ESM1, FGFR1OP, SOCS4, ADM, ADRB2, DDX11, S1PR3, FGF7, TMEM97, ID4, IFNG, IGF1, IGFBP3, IL6, IL8RB, IL11, LIFR, NAP1L1, NDN, NEDD9, NRAS, CRIM1, FGFRL1, TIPIN, C19orf10, HTRA1, CXCL5, SSR1, KLF5, TGFB2, TRAF5, VEGFA, HMGA2, CAMK2D, CDC7, BRMS1L, CREG1, FGF17, NRP1, SOCS3, SOCS6, CD47, MORF4L2 |
miRNA, microRNA; UVB, ultraviolet B; nHDP, normal human dermal papilla cell.
Figure 4GO analysis of predicted target genes. miRNA target genes were predicted using web-based TargetScan software. Biological roles of each target were analyzed by GO. A diagrammatic representation of the GO analysis was produced using GeneSpring GX. GO, gene ontology; miRNA, microRNA.
Figure 5Detailed GO analysis of cellular process, which was the highest regulated subsection of the biological process category.